TL;DR
Epimedium and its chemical constituents have been shown to inhibit tumor initiation and progression, however, further clinical studies are required to validate these findings and more comprehensive studies on its potent bioactive components, potential pharmacological effects, and administration methods are required.
AI-generated by Semantic Scholar
Authors
Shujun Wang, Haichao Wang, Yinghan Zhang, Guoliang Yin, Xin Zhang, Fengxia Zhang
